Journal of Clinical Virology
Volume 45, Issue 2 , Pages 119-124, June 2009

Cold oxygen plasma technology efficiency against different airborne respiratory viruses

  • O. Terrier

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • B. Essere

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • M. Yver

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • M. Barthélémy

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • M. Bouscambert-Duchamp

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
    • Laboratoire de virologie, centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 59 boulevard Pinel, 69677 Bron cedex, Lyon, France
  • ,
  • P. Kurtz

      Affiliations

    • Biozone Europe, 1 rue notre dame, F-59300 Valenciennes, France
  • ,
  • D. VanMechelen

      Affiliations

    • Biozone Europe, 1 rue notre dame, F-59300 Valenciennes, France
  • ,
  • F. Morfin

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
    • Laboratoire de virologie, centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 59 boulevard Pinel, 69677 Bron cedex, Lyon, France
  • ,
  • G. Billaud

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
    • Laboratoire de virologie, centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 59 boulevard Pinel, 69677 Bron cedex, Lyon, France
  • ,
  • O. Ferraris

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • B. Lina

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
    • Laboratoire de virologie, centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 59 boulevard Pinel, 69677 Bron cedex, Lyon, France
  • ,
  • M. Rosa-Calatrava

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
  • ,
  • V. Moules

      Affiliations

    • Université de Lyon, F-69000 Lyon, France
    • Université Lyon 1, Faculté de médecine RTH Laennec, France
    • CNRS FRE 3011 VirPath, Virologie et Pathologie Humaine, F-69008 Lyon, France
    • Corresponding Author InformationCorresponding author at: Université Lyon 1, F-69000 Lyon, France. Tel.: +33 4 78 77 10 36; fax: +33 4 78 77 87 51.

Received 16 December 2008; received in revised form 24 March 2009; accepted 25 March 2009. published online 30 April 2009.

Abstract 

Background

Respiratory infections caused by viruses are major causes of upper and lower respiratory tract infections. They account for an important mortality and morbidity worldwide. Amongst these viruses, influenza viruses and paramyxoviruses are major pathogens. Their transmission is mainly airborne, by direct transmission through droplets from infected cases.

Objectives

In the context of an influenza pandemic, as well as for the reduction of nosocomial infections, systems that can reduce or control virus transmission will reduce the burden of this disease. It may also be part of the strategy for pandemic mitigation.

Study design

A new system based on physical decontamination of surface and air has been developed. This process generates cold oxygen plasma (COP) by subjecting air to high-energy deep-UV light. To test its efficiency, we have developed an experimental device to assess for the decontamination of nebulized respiratory viruses. High titer suspensions of influenza virus type A, human parainfluenza virus type 3 and RSV have been tested.

Results

Different experimental conditions have been evaluated against these viruses. The use of COP with an internal device allowed the best results against all viruses tested. We recorded a reduction of 6.5, 3.8 and 4log(10) TCID50/mL of the titre of the hPIV-3, RSV and influenza virus A (H5N2) suspensions.

Conclusions

The COP technology is an efficient and innovative strategy to control airborne virus dissemination. It could successfully control nosocomial diffusion of respiratory viruses in hospital setting, and could be useful for the reduction of influenza transmission in the various consultation settings implemented for the management of cases during a pandemic.

Keywords: Influenza, Parainfluenza, Respiratory syncytial virus, Airborne transmission, Cold plasma, Germicidal ultraviolet light

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1386-6532(09)00132-2

doi:10.1016/j.jcv.2009.03.017

Journal of Clinical Virology
Volume 45, Issue 2 , Pages 119-124, June 2009